Diseases, Conditions, Syndromes

Proton pump inhibitors associated with risk of chronic kidney disease

Proton pump inhibitors (PPIs), which are commonly used drugs to reduce acid in the stomach, appear to be associated with an increased risk of chronic kidney disease but more research is needed to determine whether PPI use ...

Diseases, Conditions, Syndromes

Review examines efficacy of PPI Tx for esophageal eosinophilia

(HealthDay)—About half of patients with symptomatic esophageal eosinophilia have clinicohistologic remission with proton pump inhibitor (PPI) therapy, according to a review published in the January issue of Clinical Gastroenterology ...

Diseases, Conditions, Syndromes

Chronic PPI exposure tied to hyperparathyroidism in elderly

(HealthDay)—Chronic proton pump inhibitor (PPI) exposure is associated with mild hyperparathyroidism in elderly adults, according to a study published in the October issue of the Journal of the American Geriatrics Society.

Diseases, Conditions, Syndromes

Acid reflux medications may increase kidney disease risk

Certain medications commonly used to treat heartburn and acid reflux may have damaging effects on the kidneys, according to two studies that will be presented at ASN Kidney Week 2015 November 3-8 at the San Diego Convention ...

Other

Team studies point to clinical advantages of proton therapy

The search for evidence to support the growing use of proton therapy for more cancers at Penn Medicine continues to uncover valuable findings. New data from clinical trials conducted at the Robert Proton Therapy Center demonstrate ...

Oncology & Cancer

Simple measurement method improves accuracy in proton beam therapy

Proton beams are new high-precision weapons in the fight against cancer. However, uncertainty with regard to the range of the beams has prevented the full exploitation of the potential of this method until now. Researchers ...

page 19 from 30